Moreover, it has been demonstrated in vitro that the endothelial CD34 + progenitor cells migrate to PC sites in response to high levels of pro-angiogenic factors such as VEGF and Angiopoietin-1, secreted by tumor cells. This evidence concerns the gene CD34 and neoplasm.